| Name | Title | Contact Details |
|---|
Harken Health is a new kind of health care company that unites relationship-based primary care with a range of competitively priced insurance plan options. Our care approach is rooted in the values of a simpler time when the doctor-patient relationship mattered. Harken Health Care Teams are empowered with the time to listen and build authentic, compassionate, trusting relationships with members. Our model enables us to remove many of the barriers that often get in the way of delivering exceptional care. Strong relationships and a home base for primary care have been shown to improve patient satisfaction and lower overall medical costs. Harken is simplifying and improving the health care experience by combining our unique care approach with flexible insurance coverage. Harken Health membership includes unlimited primary care visits to Harken’s modern and inviting Harken Health Centers, complimentary health coaching, integrated behavioral health specialists, wellness classes, and 24-hour, 7-days a week access to a Harken Health doctor by phone. You`ll have access to your Care Team via office visit, phone, email or video chat. Members also have access to an expansive nationwide network of leading hospitals, specialists and other clinics. Harken Health has 10 Care Centers in the Atlanta, GA and Chicago, IL metro markets, with plans to expand to more communities soon. At Harken our goal is clear – “To change what the world expects from health care, one community at a time.”
Cannabis dispensaries in San Francisco, Santa Rosa, and Sebastopol, SPARC offers same-day cannabis delivery in San Francisco and Sonoma County.
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.
Apalachee Center Inc is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA? (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy.